Uses and Limitations of Transcutaneous Bilirubin Measurement
Introduction
June 2009
Welcome to Mayo Medical Laboratories' Hot Topics. These presentations provide short discussion of current topics and may be helpful to you in your practice.
Our presenters for this program are Dr. Brad Karon, Assistant Professor of Laboratory Medicine and Pathology and Medical Director of the Hospital Clinical Laboratories and Point of Care Testing in the Division of Clinical Core Laboratory Services at Mayo Clinic and Dr. Walter Cook, from the Division of Community Pediatric and Adolescent Medicine in the Department of Pediatric and Adolescent Medicine. Dr. Karon and Dr. Cook will provide an overview of the risk of hyperbilirubinemia in the newborn and discuss the American Academy of Pediatrics recommendations on identification and evaluation of newborn jaundice.
They will give an historic perspective on diagnosis and management, discuss the clinical picture, and discuss the uses and limitations of transcutaneous bilirubin.
Introduction |
Jump to section:
- Outline
- Introduction
- Kernicterus
- Historical Information
- Focus of the Guideline
- Key Elements to the Recommendation
- Key Elements to the Recommendation, cont.
- Mayo Study of TcB
- Mayo Study of TcB, cont.
- Mayo Study of TcB: TcB vs. diazo TsB
- Mayo Study of TcB: TcB vs Vitros TsB
- Mayo Study of TcB
- Mayo Study of TcB, cont.
- Mayo Study of TcB, cont.
- Mayo Study of TcB, cont.
- Conclusions
- Conclusions, cont.
- References
- Questions?
External
link
PDF
document
Excel
document
Word
document